Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

Moderna Inc. shares declined after the company’s first-quarter vaccine sales missed estimates and it disclosed a delay in the ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

The US Food and Drug Administration will require all new vaccines to undergo placebo-controlled trials before approval — a ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

The unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

In a statement first given to the Washington Post, the Department of Health and Human Services (HHS) said this week, "All new ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine ...